2012 Nobel Prize in Physiology or Medicine β Gurdon and Yamanaka Discover How to Turn Back Mature Cells
What You Will Learn from This Article
The 2012 Nobel Prize in Physiology or Medicine was awarded to two individuals who made groundbreaking discoveries demonstrating that mature cells can be reprogrammed to an embryonic state. John Gurdon of Cambridge, UK, in 1962, showed that the nucleus of a mature frog cell could be transferred into an enucleated egg cell, leading to the development of a complete organism. This was the foundation of somatic cell nuclear transfer experiments, and the story that eventually led to the creation of Dolly the sheep in 1996. Forty-four years later, in 2006, Shinya Yamanaka of Kyoto University, Japan, established a method to create induced pluripotent stem cells (iPS cells) by introducing just four genes (Oct4, Sox2, Klf4, c-Myc) into mouse fibroblasts. These two discoveries, though separated by time, point to the same conclusion: the identity of a cell is a reversible state, and the switches that control this state transition are a few transcription factors.
A Story That Challenges Common Sense β Cell Identity is Not a Fixed State, But a Reversible One
For most of the 20th century, the common understanding was that "once a mature cell has differentiated, its identity is fixed and cannot be reversed." Early in development, embryonic cells possess pluripotency, meaning they can differentiate into any cell type in the body. However, as development progresses, each cell becomes locked into a specific tissue identity. Myocardial cells become myocardial cells, neurons become neurons, and skin cells become skin cells. This lock was considered irreversible.
Gurdon and Yamanaka overturned this common understanding. Cell identity is a reversible state, and this state is determined by a combination of a few key transcription factors. Gurdon showed that by transferring the nucleus of a cell into the cytoplasm of an egg cell, the cytoplasmic factors could reset the nucleus to an embryonic state. Forty-four years later, Yamanaka identified these factors, narrowing them down to four genes, and demonstrated that by simply expressing these four genes inside the cell, without changing the cytoplasm, the cell could be reprogrammed.
If we frame this in a computer science context, it is state cleanup followed by a hot reboot. A mature cell is locked into a specific state, but that lock is only a combination of a few epigenetic marks. By running the correct cleanup subroutine, the state can be initialized. The Yamanaka factors are the minimum set of components for this cleanup subroutine. When Oct4, Sox2, Klf4, and c-Myc are expressed together in a cell, the epigenetic marks are reset, and the cell is rebooted into a pluripotent state.
The Landscape of the Time β K-Pop's Globalization and the First Female President
In 2012, South Korea was at the center of the cultural stage. Psy's "Gangnam Style," released on July 15th, went viral on YouTube, leading the wave of K-pop's globalization. In December, it surpassed 1 billion views, becoming the first video to do so on YouTube, and the "horse dance" was replicated in squares around the world. This video is recorded as a symbolic event in which Korean popular culture expanded from Asia to the world in the late 20th century.
On December 19th, Park Geun-hye won the presidential election. She was the first female president of South Korea, and her victory marked the return of the conservative party to power. After a close race with Moon Jae-in, she won 51.6% of the vote, and the year began with the end of Lee Myung-bak's term and the preparation for Park Geun-hye's first year in office.
In the world, on November 6th, President Obama was re-elected, defeating Mitt Romney. The Syrian civil war intensified, and the conflict between the rebels and the Assad government became internationalized. In Egypt, Mohammed Morsi of the Muslim Brotherhood became the first democratically elected president, but was overthrown in a coup the following year. On August 6th, NASA's Curiosity rover successfully landed in Gale Crater on Mars, marking a new phase in Mars exploration.
In the tech world, the patent war between Samsung and Apple reached its conclusion in court. On August 24th, a US jury found Samsung guilty of infringing Apple's patents and ordered it to pay $1 billion in damages. While the ruling has been adjusted several times since then, it was a symbolic turning point in the direct confrontation between the two giants of the smartphone market.
In the scientific community, another major event took place. In June, Doudna and Charpentier's CRISPR paper was published in Science, ushering in a new era of gene editing. The impact of this paper would lead to the Chemistry Prize in 2020, eight years later. In that year, the Nobel Prize in Physiology or Medicine recognized Yamanaka's work in opening the door to regenerative medicine, and CRISPR in opening the door to gene editing. It was a moment when these two trends converged to create the larger picture of 21st-century biotechnology.
The Story of the Individuals β Two Discoveries, 44 Years Apart, Frog and Mouse
John Gurdon (1933~) was born in Dorking, England. There is a famous anecdote that he received the lowest grade in biology at Eton College. Around the age of 15, a teacher wrote a report card saying, "It is not at all realistic for this student to dream of becoming a biologist. He lacks the ability to understand laboratory activities." He is said to have kept this report card in his office for the rest of his life. Nevertheless, he went on to study biology at Oxford University and established his own laboratory in Cambridge.
Gurdon's experiment was surprisingly simple. He used the African clawed frog (Xenopus laevis). He removed the nucleus from an unfertilized egg cell and transplanted it with the nucleus extracted from the intestinal cells of a mature tadpole. Surprisingly, some of these reconstituted eggs began to develop normally, growing into complete tadpoles. His 1962 paper demonstrated that the nucleus of a mature cell still contains all the genetic information needed for development, and that cell differentiation is not due to the loss of genetic information, but to changes in gene expression regulation.
At the time, this result did not receive much attention. Most of the scientific community thought it was an exceptional observation, and it took time for it to become established as a serious theory of development. However, in 1996, Dolly the sheep, the first mammal cloned from the nucleus of an adult somatic cell, was born in Scotland, demonstrating that Gurdon's principle also works in mammals. In the early 21st century, cloning was successful in several other species, including monkeys, dogs, pigs, and mice. Gurdon's discovery was fully validated 40 years later.
Shinya Yamanaka (1962~) was born in Osaka, Japan. He received his M.D. from Kobe University, his Ph.D. from Osaka City University, and completed his postdoctoral research at UCSF in the United States before returning to Japan. He established his own laboratory at Nara Advanced Science and Technology University and Kyoto University.
His research question was ambitious. "If there are factors in the cytoplasm that can initialize cells, how many of those factors are actually essential for initialization? Would it be possible to initialize cells without changing the cytoplasm, by simply introducing these factors into the cell?"
His approach was based on the principles of genetics. He selected 24 genes that were highly expressed in embryonic stem cells as candidates. He introduced these genes into mouse fibroblasts and observed whether they could induce initialization. By introducing all 24 genes, he observed cells that showed signs of initialization, but he narrowed down the essential factors by testing whether the cells still showed these signs when one gene at a time was removed.
His 2006 paper in Cell presented the results. The essential factors were only four: Oct4, Sox2, Klf4, and c-Myc. By introducing these four genes into mouse fibroblasts, the cells were reprogrammed to a state similar to embryonic stem cells, acquiring the ability to express pluripotency markers and differentiate into various tissues. Yamanaka named these cells iPS cells (induced pluripotent stem cells). In the following year, 2007, he succeeded in creating human iPS cells by introducing the same four genes into human fibroblasts. This was the moment when it became possible to create cells equivalent to embryonic stem cells from a person's own skin cells.
The speed of Yamanaka's discovery was remarkable. 44 years after Gurdon's discovery, and 10 years after Dolly the sheep, Yamanaka, with a bold hypothesis and systematic screening, identified the four key factors. The Nobel Prize arrived six years after this discovery, recognizing him and Gurdon together, and naming the entire flow of cell reprogramming.
Key Achievements β The Cell State Initialization Subroutine in a Computer Science Framework
If we model cell reprogramming as a pipeline, it would look like this:
- Initial State: A mature cell (e.g., a skin fibroblast) is locked into a specific identity state. The gene expression profile is tailored to that identity, and epigenetic marks maintain this state.
- Initialization Factor Introduction: The genes for the four Yamanaka factors are introduced into the cell. Originally, this was done using retroviruses to insert them into the genome, but this method has since been improved due to safety concerns, and today there are several alternatives.
- State Transition: As the factors are expressed, various gene expression programs within the cell are reorganized. The genes that were originally expressed for the cell's identity are suppressed, and the genes that are expressed in embryonic stem cells are activated. During this process, epigenetic marks are also reorganized. This state transition takes days or weeks.
- iPS State Stabilization: When cultured under specific conditions, these reprogrammed cells establish self-maintenance ability and grow into iPS cell lines that can be indefinitely proliferated. This is a state very similar to embryonic stem cells.
- Redifferentiation: Depending on the need, iPS cells can be differentiated into specific tissue cells. Protocols for differentiation into various tissues, such as myocardial cells, neurons, hepatocytes, pancreatic beta cells, and blood cells, have been established.
The key to this system is the redefinition of cell identity by a combination of key transcription factors. Cell identity is determined by a few master regulatory factors, and by changing these factors, the identity itself changes. This also opens up the possibility of direct reprogrammingβconverting one mature cell type directly into another mature cell type without going through the iPS stateβand in fact, methods have been established to directly convert fibroblasts into neurons, myocardial cells, and hepatocytes in mice.
c-Myc is an oncogene. The fact that one of the four Yamanaka factors is an oncogene was a safety concern with early iPS technology, and since then, methods have been developed to induce reprogramming with only three factors, or to replace c-Myc with other factors. This demonstrates that the power to induce state transition also carries the risk of failure in regulation.
We should also acknowledge the limitations of this analogy. iPS cells are not identical to embryonic stem cells. There is epigenetic memoryβthe phenomenon in which the identity marks of the original cell are not completely erased, but remain partiallyβand this creates subtle biases in the differentiation ability of iPS cells. iPS cells derived from myocardial cells are more easily differentiated into myocardial cells, and iPS cells derived from hepatocytes are more easily differentiated into hepatocytes. This observation that it is not a complete initialization, but a partial initialization, has become a major theme in subsequent research.
Why It Matters: Regenerative Medicine, Disease Models, and Personalized Medicine
First, it addresses the cellular resource problem in regenerative medicine. Embryonic stem cells are potential raw materials for regenerative medicine, but they pose ethical concerns due to their use of embryos and practical concerns related to immune rejection upon transplantation. iPS cells solve both of these problems simultaneously. They are created from a patient's own cells without using embryos, theoretically eliminating immune rejection. Over the past 15 years, various clinical trials have been initiated using iPS cell-derived cardiomyocytes, retinal cells, and pancreatic cells. In particular, Japan began a clinical study in 2014 involving the transplantation of iPS-derived retinal pigment epithelium (RPE) cells into patients with age-related macular degeneration, and Kyoto University's iPS Cell Research Institute, led by Yamanaka himself, is at the center of this effort.
Second, it has led to the emergence of personalized disease models. By creating iPS cells from skin cells of patients with specific genetic diseases and differentiating these iPS cells into tissues where the disease manifests, it is possible to observe the pathological processes in vitro based on the patient's own genetic background. Neurons from Parkinson's patients, neurons from Alzheimer's patients, and cardiomyocytes from patients with cardiac genetic diseases have been created using this method and are being used for research on disease mechanisms and the development of new drugs. This has opened up a new frontier of patient-specific in vitro experiments.
Third, it is combined with gene editing. A pipeline is being developed in which genes are edited in iPS cells using CRISPR, and then the cells are differentiated back into their original state before being returned to the patient. This approach has entered clinical trials for sickle cell anemia, certain immunodeficiency disorders, and hereditary blindness. A major trend in 21st-century gene and cell therapy is being developed based on iPS cells.
Fourth, it redefines the concept of cell identity itself. Our understanding of how flexible cells in adult tissues are has greatly changed. The theoretical background for research on adult tissue regeneration, such as heart regeneration, liver regeneration, and nerve regeneration, is changing here. Observations are emerging that reprogramming can occur partially in the body itself under certain conditions, and this is opening up new horizons in aging research and regenerative medicine.
Fifth, it holds the possibility of reversing aging. Recent experiments have shown that transient and partial expression of Yamanaka factors can cause cells and tissues to partially revert to a younger state. Instead of going to a complete iPS state, observations have shown that "partial reprogramming," which stops in the middle, restores several markers of aging cells, and improvements in early aging phenotypes have been reported in mice. Although application in humans is still in the experimental stage, the perspective of viewing aging itself as a controllable state change is being formed within this trend.
The meeting of a bottom-performing student from an elite school and a bold orthopedic surgeon from Japan led to the establishment of a new concept of cell identity reversal. The fact that both individuals received this award together, 44 years apart, reaffirms the fact that the big picture of science is formed on a timeline that is much longer than the rhythm of the times.
β Previous: 2011 Nobel Prize in Physiology or Medicine β Next: 2013 Nobel Prize in Physiology or Medicine